Delmotte Koen, Claeys Thomas, Poesen Koen, Dubois Bénédicte, Schrooten Maarten, Dalmau Josep, Lemmens Robin
Department of Neurology (KD, TC, BD, MS, RL), University Hospitals Leuven, Leuven, Belgium; University Hospitals Leuven (KP), Laboratory Medicine, Leuven, Belgium; KU Leuven (KP), Department of Neurosciences, Laboratory for Molecular Neurobiomarker Research, Leuven, Belgium; KU Leuven (BD), Department of Neurosciences, Laboratory for Neuroimmunology, Leuven, Belgium; Department of Neurology (JD), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Neurology (JD), University of Pennsylvania, Philadelphia, PA; Institució Catalana de Recerca i Estudis Avançats (ICREA) (JD), Barcelona, Spain; Department of Neurosciences (RL), KU Leuven-University of Leuven, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), Leuven, Belgium; and VIB (RL), Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium.
Neurol Clin Pract. 2021 Feb;11(1):e20-e21. doi: 10.1212/CPJ.0000000000000750.